Personalized vaccines: the emerging field of vaccinomics - PubMed (original) (raw)

Review

Personalized vaccines: the emerging field of vaccinomics

Gregory A Poland et al. Expert Opin Biol Ther. 2008 Nov.

Abstract

The next 'golden age' in vaccinology will be ushered in by the new science of vaccinomics. In turn, this will inform and allow the development of personalized vaccines, based on our increasing understanding of immune response phenotype: genotype information. Rapid advances in developing such data are already occurring for hepatitis B, influenza, measles, mumps, rubella, anthrax and smallpox vaccines. In addition, newly available data suggest that some vaccine-related adverse events may also be genetically determined and, therefore, predictable. This paper reviews the basis and logic of personalized vaccines, and describes recent advances in the field.

PubMed Disclaimer

Similar articles

• Application of pharmacogenomics to vaccines.
  Poland GA, Ovsyannikova IG, Jacobson RM. Poland GA, et al. Pharmacogenomics. 2009 May;10(5):837-52. doi: 10.2217/pgs.09.25. Pharmacogenomics. 2009. PMID: 19450131 Free PMC article. Review.
• Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.
  Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI. Poland GA, et al. Clin Pharmacol Ther. 2007 Dec;82(6):653-64. doi: 10.1038/sj.clpt.6100415. Epub 2007 Oct 31. Clin Pharmacol Ther. 2007. PMID: 17971814 Review.
• Vaccinomics: Paving the Way for Personalized Immunization.
  Al-Eitan LN, ElMotasem MFM, Khair IY, Alahmad SZ. Al-Eitan LN, et al. Curr Pharm Des. 2024;30(13):1031-1047. doi: 10.2174/0113816128280417231204085137. Curr Pharm Des. 2024. PMID: 38898820 Review.
• Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
  Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM; LAIV Study Group. Nolan T, et al. Pediatrics. 2008 Mar;121(3):508-16. doi: 10.1542/peds.2007-1064. Pediatrics. 2008. PMID: 18310199 Clinical Trial.
• Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
  Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC). Marin M, et al. MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12. MMWR Recomm Rep. 2010. PMID: 20448530

Cited by

• Factors influencing antibody response after COVID-19 recombinant protein vaccination in adults: A cross-sectional observational study, in Chongqing, China.
  Li J, Xu J, Liu Y, Chen L, Yu L, Xiao X, Wang Q. Li J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2389602. doi: 10.1080/21645515.2024.2389602. Epub 2024 Aug 22. Hum Vaccin Immunother. 2024. PMID: 39171541 Free PMC article.
• Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes.
  Xie J, Mothe B, Alcalde Herraiz M, Li C, Xu Y, Jödicke AM, Gao Y, Wang Y, Feng S, Wei J, Chen Z, Hong S, Wu Y, Su B, Zheng X, Cohet C, Ali R, Wareham N, Alhambra DP. Xie J, et al. Nat Commun. 2024 May 13;15(1):4031. doi: 10.1038/s41467-024-48339-5. Nat Commun. 2024. PMID: 38740772 Free PMC article.
• A targeted approach to vaccine hesitancy.
  Leston M, de Lusignan S, Hobbs FDR. Leston M, et al. Oxf Open Immunol. 2023 Oct 28;4(1):iqad007. doi: 10.1093/oxfimm/iqad007. eCollection 2023. Oxf Open Immunol. 2023. PMID: 38089637 Free PMC article.
• Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations.
  Purcell RA, Theisen RM, Arnold KB, Chung AW, Selva KJ. Purcell RA, et al. Front Immunol. 2023 Jun 27;14:1183727. doi: 10.3389/fimmu.2023.1183727. eCollection 2023. Front Immunol. 2023. PMID: 37600816 Free PMC article. Review.
• An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines.
  Bayani F, Hashkavaei NS, Arjmand S, Rezaei S, Uskoković V, Alijanianzadeh M, Uversky VN, Ranaei Siadat SO, Mozaffari-Jovin S, Sefidbakht Y. Bayani F, et al. Prog Biophys Mol Biol. 2023 Mar;178:32-49. doi: 10.1016/j.pbiomolbio.2023.02.004. Epub 2023 Feb 18. Prog Biophys Mol Biol. 2023. PMID: 36801471 Free PMC article. Review.

References

1. 1. Black FL, Schiffman G, Pandey JP. HLA, Gm, and Km polymorphisms and immunity to infectious diseases in South Amerinds. Exp Clin Immunogenet. 1995;12:206–16. - PubMed
2. 1. Granoff DM, Pandey JP, Boies E, et al. Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype. J Clin Invest. 1984;74:1708–14. - PMC - PubMed
3. 1. Poland GA, Ovsyannikova IG, Jacobson RM. Vaccine immunogenetics: bedside to bench to population. Vaccine. 2008 In press.• This paper provides a review of immunogenetic determinants of measles vaccine response.
4. 1. Poland GA, Jacobson RM. The genetic basis for variation in antibody response to vaccines. Curr Opin Pediatr. 1998;10:208–15. - PubMed
5. 1. Poland GA. Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response. Am J Hum Genet. 1998;62(2):215–20. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

• R01 AI033144/AI/NIAID NIH HHS/United States
• N01 AI040065/AI/NIAID NIH HHS/United States
• R01 AI048793-08/AI/NIAID NIH HHS/United States
• N01AI40065/AI/NIAID NIH HHS/United States
• R01 AI048793/AI/NIAID NIH HHS/United States
• R01 AI033144-14A2/AI/NIAID NIH HHS/United States
• R37 AI048793/AI/NIAID NIH HHS/United States
• AI 48793/AI/NIAID NIH HHS/United States
• AI 33144/AI/NIAID NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Taylor & Francis

• Medical

  • MedlinePlus Health Information